STOCK TITAN

Rhythm Pharmaceuticals (RYTM) Total Assets by Year

RYTM NASDAQ

Rhythm Pharmaceuticals, Inc. closed fiscal year 2025 with $480.2M in total assets, $341.1M in total liabilities and $139.1M in shareholder equity. Total assets rose 22.4% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Rhythm Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Total Assets $480.2M
Total Liabilities $341.1M
Total Equity $139.1M
YoY +22.4%
5Y CAGR +20.7%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RYTM Balance Sheet by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY21FilingFY2010-KFY1910-KFY1810-KFY17FilingFY16FilingFY1510-K
Total Assets$480.2M+22.4%$392.3M+17.9%$332.7M-13.0%$382.5M+16.1%$329.5M+76.1%$187.1M-39.4%$308.5M+18.6%$260.2M+71.5%$151.7M+1129.7%$12.3MN/A
Total Liabilities$341.1M-7.9%$370.5M+127.3%$163.0M+37.9%$118.2M+160.6%$45.4M+120.8%$20.5M-25.3%$27.5M+97.1%$14.0M+100.8%$6.9M-84.6%$45.0MN/A
Total Equity$139.1M+540.0%$21.7M-87.2%$169.8M-35.8%$264.3M-7.0%$284.2M+70.6%$166.5M-40.7%$281.0M+14.1%$246.3M+70.1%$144.8Mn/m-$32.7Mn/m-$8.0M

RYTM Balance Sheet by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Total Assets$443.1M-12.6%$437.3M+17.3%$442.3M+14.4%$480.2M+22.4%$506.9M+39.4%$372.7M-2.4%$386.7M+49.5%$392.3M+17.9%$363.6M+2.6%$381.8M+23.2%$258.7M-25.2%$332.7M-13.0%
Total Liabilities$355.2M-0.8%$334.3M-13.1%$319.4M-13.1%$341.1M-7.9%$358.1M+1.6%$384.6M+12.3%$367.7M+86.6%$370.5M+127.3%$352.4M+124.8%$342.5M+168.3%$197.1M+56.5%$163.0M+37.9%
Total Equity$88.0M-40.9%$103.0Mn/m$122.9M+548.7%$139.1M+540.0%$148.8M+1226.9%-$11.9M-130.3%$18.9M-69.2%$21.7M-87.2%$11.2M-94.3%$39.3M-78.4%$61.6M-72.0%$169.8M-35.8%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Rhythm Pharmaceuticals, Inc. financials

Frequently Asked Questions

Rhythm Pharmaceuticals, Inc. closed fiscal year 2025 with $480.2M in total assets, $341.1M in total liabilities and $139.1M in shareholder equity.

Rhythm Pharmaceuticals, Inc. (RYTM) total assets rose by 22.4% year over year, from $392.3M to $480.2M in fiscal year 2025.

Rhythm Pharmaceuticals, Inc. (RYTM) reported $443.1M in total assets in Q3 2026. This represents a decrease of 12.6% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Rhythm Pharmaceuticals, Inc. (RYTM) reported on that line in every period on record.